Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Vireo Growth ( (TSE:VREO) ) just unveiled an update.
Vireo Growth Inc. has announced a strategic licensing agreement with Curio Wellness to manufacture and distribute Curio’s Best Self Collection in New York. This partnership allows Curio to expand into the New York market without significant investment, while Vireo enhances its product offerings with Curio’s nationally recognized, high-quality cannabis products. The collaboration is expected to strengthen Vireo’s market position and deliver premium offerings to health-conscious consumers in New York.
The most recent analyst rating on (TSE:VREO) stock is a Hold with a C$0.55 price target. To see the full list of analyst forecasts on Vireo Growth stock, see the TSE:VREO Stock Forecast page.
More about Vireo Growth
Vireo Growth Inc. is a multi-state, vertically-integrated cannabis operator known for its disciplined and strategically aligned platform. The company focuses on leveraging a national portfolio while maintaining a local presence, aiming to deliver value to customers, employees, shareholders, and communities. Curio Wellness is a cGMP-certified, vertically integrated cannabis company that develops innovative health and wellness products, emphasizing science, integrity, and wellness-centered design.
Average Trading Volume: 26,947
Technical Sentiment Signal: Sell
Current Market Cap: C$552.9M
For a thorough assessment of VREO stock, go to TipRanks’ Stock Analysis page.